Filing Details

Accession Number:
0001209191-12-002629
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-01-06 19:48:37
Reporting Period:
2012-01-06
Filing Date:
2012-01-06
Accepted Time:
2012-01-06 19:48:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1103390 Ardea Biosciences Inc. RDEA Pharmaceutical Preparations (2834) 943200380
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1131146 Stephen Davis 4939 Directors Place
San Diego CA 92121
Evp & Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-01-06 218 $15.55 16,922 No 4 F Direct
Common Stock Disposition 2012-01-06 700 $15.91 16,222 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Footnotes
  1. Represents vested shares of restricted stock that were withheld by the Issuer to satisfy the tax liability associated with the 521 shares that vested on January 6, 2012.
  2. The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of September 23, 2010.
  3. The range of sales prices received was $15.77 to $16.10. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.